The race to treat COVID-19: Potential therapeutic agents for the prevention and treatment of SARS-CoV-2.

ABSTRACT: The unforeseen emergence of coronavirus disease 2019 (COVID-19), a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at the Wuhan province of China in December 2019, subsequently its abrupt spread across the world has severely affected human life. In a short span of time, COVID-19 has sacked more than one million human lives and marked as a severe global pandemic, which is drastically accountable for the adverse effect directly to the human society, particularly the health care system and the economy. The unavailability of approved and effective drugs or vaccines against COVID-19 further created conditions more adverse and terrifying. To win the war against this pandemic within time there is a desperate need for the most adequate therapeutic treatment, which can be achieved by t

SUBMITTER: Shagufta 

PROVIDER: S-EPMC7802596 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature